NMPA Approval

Cefoperazone Sodium and Tazobactam Sodium for Injection（Ⅰ）

Approval Number

国药准字H20183492

Company海南美好西林生物制药有限公司

Registration Date

December 6, 2023

Drug Information

Generic Name

注射用头孢哌酮钠他唑巴坦钠(Ⅰ)

Dosage Form

注射剂

Strength

1.0g（C25H27N9O8S2 0.8g与C10H12N4O5S 0.2g）

Drug Type

化学药品

Registration Date

December 6, 2023

Company Information

Applicant Company

Company Name海南美好西林生物制药有限公司

Company Address

海口市美兰区桂林洋开发区26号

Manufacturing Company

Company Name海南美好西林生物制药有限公司

Company Address

海口市美兰区桂林洋开发区26号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

注射用头孢哌酮钠他唑巴坦钠(Ⅰ) - NMPA 批准文号 | MedPath